PDB13 A Cost of Control Analysis of Liraglutide Versus Other ANTI-Diabetic Therapies in the Treatment of Patient with Type 2 Diabetes in China
Abstract
Authors
A. Shen P. Zhu L. Ning P. Fang C. Xing
A. Shen P. Zhu L. Ning P. Fang C. Xing
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now